HOME >> BIOLOGY >> NEWS
Hot on the TRAIL of controlling inflammation in bacterial meningitis

In a study appearing online on June 14 in advance of publication in the July print issue of the Journal of Clinical Investigation, researchers at Charit Universittsmedizin Berlin report that the molecule known as TRAIL can limit excessive immune responses in bacterial meningitis and as such may be of use to control inflammation of the spinal cord and brain, which causes brain cell death in this life-threatening disease.

Pneumococcal meningitis involves inflammation of the protective membranes covering the brain and spinal cord and is caused by infection with the bacterium Streptococcus pneumoniae. The observed swelling of the brain is largely the result of the excessive immune response to infection. The tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) has been previously reported to play a role in the regulation of the host immune response. In the current study, Joerg Weber and colleagues administered components of Streptococcus pneumoniae bacteria to the cerebrospinal fluid bathing the brain and spinal cord of mice lacking TRAIL. They found that these animals suffered from increased inflammation and brain cell death, however these effects were reversed by the administration of recombinant TRAIL (rTRAIL). Importantly, the application of rTRAIL to mice with intact TRAIL and meningitis also decreased inflammation and neuronal cell death. Finally, the authors observed that human patients with bacterial meningitis showed increased synthesis in the cerebrospinal fluid of TRAIL. The results of the study provide evidence that TRAIL acts to limit inflammation of the brain and spinal cord during bacterial meningitis, suggesting that it may be of use as an anti-inflammatory agent in invasive bacterial infections.


'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
14-Jun-2007


Page: 1

Related biology news :

1. Scientists follow familiar TRAIL to new cancer therapy
2. Is liver damage down the TRAIL for a promising cancer therapy?
3. Decreased breast cancer survival associated with high TRAIL-R2 expression
4. Revealed -- Mosquito genes that could be controlling the spread of killer viruses
5. Antibody-based therapies effective at controlling malaria
6. Information processing in the central nervous system: the signalling system controlling movement
7. Gene controlling circadian rhythms may be involved in onset of bipolar disorder
8. Edge density key to controlling gypsy moth spread
9. Electronic chip, interacting with the brain, modifies pathways for controlling movement
10. Climate change not the only factor controlling distribution of plant species
11. Important gene controlling tree growth and development found

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2020)... N.M. (PRWEB) , ... April 28, 2020 , ... ... the world’s biggest challenges in agriculture and aquaculture with the mission of improving global ... at the 2020 F&A Next ' Next Heroes in Food- and Ag-Tech ' virtual ...
(Date:4/26/2020)... ... April 23, 2020 , ... ... miniaturization, backed by FII Tech Growth managed by Fondo Italiano d’Investimento SGR, today ... market, for the development of Respira, a new non-invasive pulmonary ventilator created in ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... Ideaship, a patent leveraged venture capital firm that provides patent development support for ... to detect and treat illnesses such as ovarian cancer and precancerous pancreatic lesions ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... This new service offers clients a way to ... answered quickly as the need arises. Lachman’s OnCall SMEs have extensive knowledge of a ... , Lachman OnCall™ SMEs are available normal business hours Monday through Friday from ...
(Date:5/14/2020)... , ... May 13, 2020 , ... ... assays or phenotypic readouts, providing little or no information on the drug’s mechanism ... more comprehensive characterization of compounds by measuring the activity of molecular pathways. This ...
(Date:5/1/2020)... ... April 30, 2020 , ... The ... the businesses, policies, projects, and concepts that are actively engaged and deeply committed ... cells, which has taken out the top prize in the Experimental category. , ...
(Date:4/22/2020)... ARBOR, Mich. (PRWEB) , ... April 21, 2020 ... ... clinical researchers continue their work through COVID-19. Many clinical trial teams are working ... work online. Ripple Science wants to help researchers continue their research during this ...
Breaking Biology Technology:
Cached News: